Cyclerion Therapeutics Management
How experienced are the management team and are they aligned to shareholders interests?
2.5yrs
Average management tenure
CEO
Peter Hecht (58 yo)
3.75yrs
Tenure
US$108,220
Compensation
Dr. Peter M. Hecht, Ph D., served as the Chief Executive Officer of Ironwood Pharmaceuticals, Inc. since 1998 until April 1, 2019. Dr. Hecht is Chief Executive Officer and Director of Cyclerion Therapeutic...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$48m |
| Jun 30 2022 | n/a | n/a | -US$48m |
| Mar 31 2022 | n/a | n/a | -US$51m |
| Dec 31 2021 | US$108k | US$100k | -US$52m |
| Sep 30 2021 | n/a | n/a | -US$60m |
| Jun 30 2021 | n/a | n/a | -US$68m |
| Mar 31 2021 | n/a | n/a | -US$71m |
| Dec 31 2020 | US$366k | US$104k | -US$78m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$93m |
| Mar 31 2020 | n/a | n/a | -US$106m |
| Dec 31 2019 | US$122k | US$71k | -US$123m |
| Sep 30 2019 | n/a | n/a | -US$128m |
| Jun 30 2019 | n/a | n/a | -US$130m |
| Mar 31 2019 | n/a | n/a | -US$127m |
| Dec 31 2018 | US$5m | US$100k | -US$115m |
Compensation vs Market: Peter's total compensation ($USD108.22K) is below average for companies of similar size in the US market ($USD727.78K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.75yrs | US$108.22k | 4.71% $ 1.3m | |
| Chief Operating Officer | 2yrs | US$664.35k | 0.032% $ 8.8k | |
| CFO & Corporate Secretary | 3.08yrs | no data | no data | |
| Senior Vice President of External Innovation | 1yr | no data | no data | |
| Associate Director of Corporate Communications | no data | no data | no data |
2.5yrs
Average Tenure
42yo
Average Age
Experienced Management: CYCN's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.75yrs | US$108.22k | 4.71% $ 1.3m | |
| Independent Director | 3.75yrs | US$75.99k | 0.016% $ 4.3k | |
| Independent Director | 3.75yrs | US$75.49k | 0.010% $ 2.7k | |
| Independent Director | 1.75yrs | US$56.58k | 0% $ 0 | |
| Independent Chairman | 3.83yrs | US$94.49k | 0.039% $ 10.7k | |
| Independent Director | 3.75yrs | US$70.49k | 0.0056% $ 1.5k | |
| Chair of Scientific Advisory Board | no data | US$366.78k | no data | |
| Independent Director | 3.75yrs | US$67.99k | 0.0056% $ 1.5k | |
| Independent Director | 3.75yrs | US$74.49k | 0.0056% $ 1.5k | |
| Member of Clinical Advisory Board | 1.83yrs | US$767.08k | no data | |
| Member of Clinical Advisory Board | 2yrs | no data | no data | |
| Member of Clinical Advisory Board | 2yrs | no data | no data |
3.8yrs
Average Tenure
66yo
Average Age
Experienced Board: CYCN's board of directors are considered experienced (3.8 years average tenure).